Daniel Nadler started OpenEvidence to help physicians sort through a deluge of medical research. Now, he’s raised $210 million at a $3.5 billion valuation.| Forbes
Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug powerhouse and has become one of the world’s most successful female entrepreneurs.| Forbes